Case report form
Case report form (often abbreviated as CRF) is a specialized document in clinical research designed to collect the patient data in a structured and standardized manner. The primary purpose of a case report form is to provide a clear and concise framework for the collection of patient data in clinical trials.
Overview[edit | edit source]
A case report form is a data recording document used in clinical trials. It is used to maintain and manage patient data collected during a clinical trial. The CRF is designed to collect specific data related to the clinical trial's objectives and to monitor the patient's health during the trial.
Design and Structure[edit | edit source]
The design and structure of a case report form can vary depending on the nature of the clinical trial. However, it typically includes sections for patient demographics, medical history, trial-specific data, and follow-up information. The form is designed to be easy to understand and fill out, with clear instructions and definitions for each field.
Use in Clinical Trials[edit | edit source]
In a clinical trial, the case report form is used by the clinical research team to collect and record data from each participating patient. The data collected on the CRF includes information about the patient's health status, the treatment they are receiving, and any adverse events or side effects they experience during the trial. This data is then used to evaluate the safety and efficacy of the treatment being studied.
Electronic Case Report Forms[edit | edit source]
With the advancement of technology, many clinical trials now use electronic case report forms (eCRFs). These digital forms offer several advantages over traditional paper-based CRFs, including improved data accuracy, real-time data access, and streamlined data management processes.
Regulatory Compliance[edit | edit source]
Case report forms must comply with regulatory guidelines set forth by organizations such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These guidelines ensure that the data collected is reliable, accurate, and can be used to make informed decisions about the safety and efficacy of new treatments.
See Also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
